IDEAYA Biosciences Inc. Stock News

IDEAYA Biosciences, Inc. (Nasdaq:IDYA) is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using mole

IDEAYA Biosciences (NASDAQ:IDYA) VP Jason Throne sold 2,205 shares of the company’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $8.66, for a total tran

Medical laboratory professionals and quality assurance officers have been equipped with strategies necessary for the achievement of quality healthcare in Nigeria at the 5th edition of the ISN Quality

IDEAYA (IDYA) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

IDEAYA Biosciences, Inc. (Nasdaq: IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molec

ISN Medical, the leading supplier of medical diagnostics products and services, has scheduled the fifth edition of its quality assurance summit for Saturday, June 6, 2020. The quarterly event known as

It’s been a busy week for Repare Therapeutics. On Tuesday, the cancer drug developer struck up an alliance with Bristol Myers Squibb (NYSE: ]) that pays

The

The "Molecular Diagnostics - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis...

The

Out on Wall Street, stocks were able to pull out a major win. Despite being a more volatile week of trading, the three major U.S. stock indexes were each able to notch a more than 3% weekly-gain, with

IDEAYA Biosciences, Inc. (Nasdaq:IDYA), an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecu

The